Article Text

PDF
Skewed X inactivation in an X linked nystagmus family resulted from a novel, p.R229G, missense mutation in the FRMD7 gene
  1. Y Kaplan1,
  2. I Vargel2,
  3. T Kansu3,
  4. B Akin4,
  5. E Rohmann5,6,
  6. S Kamaci7,
  7. E Uz8,
  8. T Ozcelik8,
  9. B Wollnik5,6,
  10. N A Akarsu4,9
  1. 1
    Department of Neurology, Gaziosmanpaşa University, Medical Faculty, Tokat, Turkey
  2. 2
    Department of Plastic and Reconstructive Surgery, Hacettepe University Medical Faculty, Ankara, Turkey
  3. 3
    Department of Neurology, Hacettepe University Medical Faculty, Ankara, Turkey
  4. 4
    Gene Mapping Laboratory, Pediatric Hematology Unit, Hacettepe University Medical Faculty, Ankara, Turkey
  5. 5
    Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany
  6. 6
    Institute of Human Genetics, University of Cologne, Cologne, Germany
  7. 7
    Department of Orthodontics, Hacettepe University, Faculty of Dentistry, Ankara, Turkey
  8. 8
    Department of Molecular Biology and Genetics, Bilkent University, Faculty of Science, Ankara, Turkey
  9. 9
    Department of Medical Genetics, Hacettepe University Medical Faculty, Ankara, Turkey
  1. N A Akarsu, Hacettepe University Medical Faculty, Department of Pediatrics, Pediatric Hematology Unit, Gene Mapping Laboratory, Room No. 24, Sihhiye, 06100, Ankara, Turkey; nakarsu{at}hacettepe.edu.tr

Abstract

Aims: This study aimed to identify the underlying genetic defect of a large Turkish X linked nystagmus (NYS) family.

Methods: Both Xp11 and Xq26 loci were tested by linkage analysis. The 12 exons and intron–exon junctions of the FRMD7 gene were screened by direct sequencing. X chromosome inactivation analysis was performed by enzymatic predigestion of DNA with a methylation-sensitive enzyme, followed by PCR of the polymorphic CAG repeat of the androgen receptor gene.

Results: The family contained 162 individuals, among whom 28 had NYS. Linkage analysis confirmed the Xq26 locus. A novel missense c.686C>G mutation, which causes the substitution of a conserved arginine at amino acid position 229 by glycine (p.R229G) in exon 8 of the FRMD7 gene, was observed. This change was not documented in 120 control individuals. The clinical findings in a female who was homozygous for the mutation were not different from those of affected heterozygous females. Skewed X inactivation was remarkable in the affected females of the family.

Conclusions: A novel p.R229G mutation in the FRMD7 gene causes the NYS phenotype, and skewed X inactivation influences the manifestation of the disease in X linked NYS females.

Statistics from Altmetric.com

Footnotes

  • Funding: This study was supported by The Hacettepe University Research Foundation (number 00-01-101-010), The Scientific and Technological Research Council of Turkey (number TUBITAK-SBAG 3334) and The International Centre for Genetic Engineering and Biotechnology (ICGEB-CRP/TUR04-01).

  • Competing interests: None.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.